http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103805569-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
| filingDate | 2014-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103805569-B |
| titleOfInvention | The preparation of people ICF45 monoclonal antibody and application thereof |
| abstract | The invention discloses preparation and the application thereof of people ICF45 monoclonal antibody.Does is a kind of preserving number provided by the invention CGMCC? mouse hybridoma cell (the mus of No.8456? musculus? hybridoma) F6E4C12F11.Does is additionally providing by preserving number CGMCC? mouse hybridoma cell (the mus of No.8456? musculus? hybridoma) monoclonal antibody of F6E4C12F11 generation.Experiment of the present invention proves, does the present invention's screening obtain 1 strain mouse hybridoma cell (mus? musculus? hybridoma) F6E4C12F11, and Identification of Biological Characteristics is carried out to it, to inquiring into ICF45 further in the impact of protein level on the normal physiological process of cell, and foundation is provided and lays the foundation for the further investigation playing respective action relation and function thereof in disease, tumour and transformation reactions, preparation suppresses the potential drug albumen of corresponding disease. |
| priorityDate | 2014-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 18.